↓ Skip to main content

IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines

Overview of attention for article published in Frontiers in immunology, September 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines
Published in
Frontiers in immunology, September 2022
DOI 10.3389/fimmu.2022.952231
Pubmed ID
Authors

Zhiliang Jia, Dristhi Ragoonanan, Kris Michael Mahadeo, Jonathan Gill, Richard Gorlick, Elizabeth Shpal, Shulin Li

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 57 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 6 11%
Researcher 6 11%
Student > Master 5 9%
Student > Ph. D. Student 4 7%
Student > Bachelor 3 5%
Other 8 14%
Unknown 25 44%
Readers by discipline Count As %
Immunology and Microbiology 10 18%
Unspecified 6 11%
Biochemistry, Genetics and Molecular Biology 6 11%
Agricultural and Biological Sciences 2 4%
Chemistry 2 4%
Other 6 11%
Unknown 25 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2023.
All research outputs
#5,039,275
of 26,179,695 outputs
Outputs from Frontiers in immunology
#5,626
of 33,036 outputs
Outputs of similar age
#99,792
of 440,381 outputs
Outputs of similar age from Frontiers in immunology
#273
of 2,000 outputs
Altmetric has tracked 26,179,695 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,036 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,381 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 2,000 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.